BYNRAFT

Serial Number 79413084
Registration 7805865
700

Registration Progress

Application Filed
Oct 31, 2024
Under Examination
Approved for Publication
Apr 2, 2025
Published for Opposition
Apr 8, 2025
Registered
May 27, 2025

Trademark Image

BYNRAFT

Basic Information

Serial Number
79413084
Registration Number
7805865
Filing Date
October 31, 2024
Registration Date
May 27, 2025
Published for Opposition
April 8, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 27, 2025
Registration
Registered
Classes
005

Rights Holder

NOVARTIS AG

25
Address
CH-4002 Basel
CH

Ownership History

NOVARTIS AG

Original Applicant
25
CH

NOVARTIS AG

Owner at Publication
25
CH

NOVARTIS AG

Original Registrant
25
CH

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

Next Deadline
2140 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-05-27)
Due Date
May 27, 2031
Grace Period Ends
November 27, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

13 events
Date Code Type Description Documents
Jun 26, 2025 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
May 27, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 27, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 8, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 7, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Apr 7, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Apr 7, 2025 ECDR I TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Loading...
Apr 2, 2025 NPUB O NOTICE OF PUBLICATION Loading...
Mar 13, 2025 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 12, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 3, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 30, 2024 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Dec 26, 2024 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification

International Classes
005